As of 2025-05-23, the Intrinsic Value of Jiangsu Sihuan Bioengineering Co Ltd (000518.SZ) is (1.01) CNY. This 000518.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 2.14 CNY, the upside of Jiangsu Sihuan Bioengineering Co Ltd is -147.00%.
The range of the Intrinsic Value is (1.72) - (0.73) CNY
Based on its market price of 2.14 CNY and our intrinsic valuation, Jiangsu Sihuan Bioengineering Co Ltd (000518.SZ) is overvalued by 147.00%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | (1.72) - (0.73) | (1.01) | -147.0% |
DCF (Growth 10y) | (0.76) - (1.65) | (1.01) | -147.3% |
DCF (EBITDA 5y) | (1.28) - (1.73) | (1,234.50) | -123450.0% |
DCF (EBITDA 10y) | (1.05) - (1.53) | (1,234.50) | -123450.0% |
Fair Value | -0.60 - -0.60 | -0.60 | -127.90% |
P/E | (2.93) - (2.93) | (3.02) | -241.2% |
EV/EBITDA | (2.98) - (1.73) | (2.30) | -207.4% |
EPV | (0.45) - (0.63) | (0.54) | -125.2% |
DDM - Stable | (0.87) - (2.92) | (1.90) | -188.7% |
DDM - Multi | (0.52) - (1.41) | (0.77) | -135.8% |
Market Cap (mil) | 2,203.26 |
Beta | 1.58 |
Outstanding shares (mil) | 1,029.56 |
Enterprise Value (mil) | 2,231.52 |
Market risk premium | 6.13% |
Cost of Equity | 10.62% |
Cost of Debt | 5.00% |
WACC | 10.53% |